45 assets in Carcinoma

[18f]f-resca-rt4

[18F]F-RESCA-T4

[68ga]ga-nota-rt4

[68ga]ga-nota-t4

Nivolumab

Cyclophosphamide

Durvalumab

Eflornithine

Pemigatinib

Amxt1501

Fluorouracilum

Fulvestrant

h1299 cell lysates

Montanide Isa 51

Olaparib

S<Sup>3.15</Sup>,S<Sup>3.22</Sup>,S<Sup>3.29</Sup>-[(1,3,5-Triazinane-1,3,5-Triyl)Tris(3-Oxopropane-3,1-Diyl)]{N-[5-Oxo-5-({L-Valyl-N<Sup>5</Sup>-Carbamoyl-L-Ornithyl[(4-Aminophenyl)Methoxy]Carbonyl-N-Methyl-L-Valyl-Lvalyl-(3R,4S,5S)-3-Methoxy-5-Methyl-4-(Methylamino)Heptanoyl-(2R,3R)-N-[(1S,2R)-1-Hydroxy-1-Phenylpropan-2-Yl]-3-Methoxy-2-Methyl-3-[(2S)-Pyrrolidin-2-Yl]Propanamide}-N2.1-Yl)Pentanoyl]-?-Alanyldecakis(N-Methylglycyl)-L-Alanyl-N6-Carbamimidoyl-L-Lysyl-L-?-Aspartyl-L-Cysteinyl-(4R)-4-Hydroxy-L-Prolyl-L-Leucyl-L-Valyl-L-Asparaginyl-L-Prolyl-L-Leucyl-L-Cysteinyl-L-Leucyl-L-Histidyl-L-Prolyl-D-?-Aspartyl-L-Tryptophyl-N6-Carbamimidoyl-L-Lysyl-Lcysteinamide}

Mirdametinib

Cetuximab

Panitumumab

s241656

Pembrolizumab

Amt-151

mt-302

18f-trx

89-zr-dfo-star polyethylene glycol

Avutometinib

azd1390

Belzutifan

CD47/SIRPA-BLOCKING AGENT ALX148

cf33-hnis

dm001

dm002

dm005

Fam-Trastuzumab Deruxtecan-Nxki

Inv-1120

Msk-Tcr5

Nogapendekin Alfa Inbakicept

Tucatinib

Zanidatamab

Zirconium Zr 89-Dfo-Ys5

Nextgen-Til

92.3% TO NMT 93.8% ETHANOL BY WEIGHT IN WATER

Adriamycin

agx101

Certirobell®